MARKET

ALPN

Alpine Immune Sc
ALPN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-8.1917
75.35
12.80
4,456,781,329.19
UPDATE 1-US Q2 earnings growth estimate dips, reflecting Vertex loss, LSEG says
Reuters · 08/02/2024 20:01
Alpine Immune Sc: Securities to be offered to employees in employee benefit plans, post-effective amendments
Press release · 05/20/2024 16:04
Weekly Report: what happened at ALPN last week (0513-0517)?
Weekly Report · 05/20/2024 11:31
What 11 Analyst Ratings Have To Say About Alpine Immune Sciences
Benzinga · 05/16/2024 13:00
Alpine Immune Sciences Price Target Maintained With a $65.00/Share by Wedbush
Dow Jones · 05/16/2024 12:48
Wedbush Reiterates Neutral on Alpine Immune Sciences, Maintains $65 Price Target
Benzinga · 05/16/2024 12:38
Analysts Offer Insights on Healthcare Companies: Eyenovia (EYEN), Alpine Immune Sciences (ALPN) and GoodRx Holdings (GDRX)
TipRanks · 05/16/2024 12:20
ALPN Factor-Based Stock Analysis
NASDAQ · 05/15/2024 20:12
More

Webull offers Alpine Immune Sc stock information, including NASDAQ: ALPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPN stock methods without spending real money on the virtual paper trading platform.